2016
DOI: 10.4172/2325-9795.1000248
|View full text |Cite
|
Sign up to set email alerts
|

Prevalence and Factors Associated with Toxoplasma Gondii Immunization among Pregnant Women in Douala – Cameroon

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1
1

Citation Types

5
9
2

Year Published

2019
2019
2023
2023

Publication Types

Select...
4
2

Relationship

0
6

Authors

Journals

citations
Cited by 9 publications
(16 citation statements)
references
References 0 publications
5
9
2
Order By: Relevance
“…In the coastal region of Cameroon, a rate of 71.8% (out of 170 pregnant women) was reported in the health district of Limbe (10). Values close to the rates reported above were also recorded in 2016; 54.5% (out of 178 women of child-bearing age) at Njinikom, north-western region (11) and 78.6% (out of 327 pregnant women) in Douala (12). All these studies emphasize the need to sensitize pregnant women to the disease and its mode of transmission during their prenatal follow-up, in order to reduce the risk of first infection during their pregnancy.…”
Section: Introductionsupporting
confidence: 76%
“…In the coastal region of Cameroon, a rate of 71.8% (out of 170 pregnant women) was reported in the health district of Limbe (10). Values close to the rates reported above were also recorded in 2016; 54.5% (out of 178 women of child-bearing age) at Njinikom, north-western region (11) and 78.6% (out of 327 pregnant women) in Douala (12). All these studies emphasize the need to sensitize pregnant women to the disease and its mode of transmission during their prenatal follow-up, in order to reduce the risk of first infection during their pregnancy.…”
Section: Introductionsupporting
confidence: 76%
“…Following Cochran's formula (1963) [ 35 ], a total sample size of 342 was calculated from a previous Toxoplasma seroprevalence of 65.5% among pregnant women in Douala, Littoral Region of Cameroon [ 22 ]. Sampling of pregnant women was done by convenience, and 360 pregnant women were approached with consent forms to sign after study was explained to them, but 310 fully consented to the study.…”
Section: Methodsmentioning
confidence: 99%
“…Existing reports showed a prevalence of 68.4% in Brazil [ 14 ], 6.4% in South Africa [ 15 ], 42.5% in Malaysia [ 16 ], 36.7% in France [ 17 ], 92.5% in Ghana [ 18 ], 5.87% in Zambia [ 19 ], 30.9% in Tanzania [ 20 ], and 20.3% in Burkina Faso [ 21 ]. In different regions of Cameroon, seroprevalence of over 50% have been reported [ 22 25 ], while other regions have had seroprevalence rates of less than 50% [ 26 , 27 ].…”
Section: Introductionmentioning
confidence: 99%
“…The studies qualified for the review were conducted in 12 countries in Africa. Thirteen (36.1%) of these studies were from eastern Africa [19][20][21][22][23][24][25][26][27][28][29][30][31], 12 (33.3%) from western Africa [12,[32][33][34][35][36][37][38][39][40][41][42], 5 (13.9%) from northern Africa [43][44][45][46][47], five (13.9%) from central Africa [17,18,[48][49][50] and one (2.8%) were from southern Africa [11]. The overall number of study participants included in this meta-analysis was 10,701 and 4,242 pregnant women for IgG and IgM respectively.…”
Section: Characteristics Of Included Studiesmentioning
confidence: 99%